Unz Review

When the Pfizer and Moderna vaccines first proved their efficacy, preventing nearly 95% of coronavirus infections in those who got the shots in test trials, a vexing issue immediately arose. Who should get priority in receiving these life-saving shots? Generally speaking, the answer, while differing slightly from state to state, was that those most vulnerable…Read full article at The Unz Review

Leave a Reply

Your email address will not be published. Required fields are marked *